Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS | $1.3 | $0.8 | ($2.8) | ($0.3) | ($1.4) | ($0.7) | ($0.7) | $0.3 | ($2.9) | ($0.1) | $0.2 | ($0.2) | $0.3 | $0.1 | $1.2 | $3.4 | ($0.1) | $0.7 | $0.5 | $1.1 |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Boston Scientific Corporation's last 12-month EPS is $1.2, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Boston Scientific Corporation's EPS growth was 49.1%. The average annual EPS growth rates for Boston Scientific Corporation have been 110.9% over the past three years, 9.1% over the past five years.
Over the last year, Boston Scientific Corporation's EPS growth was 49.1%, which is higher than industry growth of (0.2%). It indicates that Boston Scientific Corporation's EPS growth is Good.